Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H12N2OS2 |
| Molecular Weight | 252.356 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C1CN(CCO1)SC2=NC3=C(S2)C=CC=C3
InChI
InChIKey=MHKLKWCYGIBEQF-UHFFFAOYSA-N
InChI=1S/C11H12N2OS2/c1-2-4-10-9(3-1)12-11(15-10)16-13-5-7-14-8-6-13/h1-4H,5-8H2
| Molecular Formula | C11H12N2OS2 |
| Molecular Weight | 252.356 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/18845111Curator's Comment: Description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/3180764 and https://www.smartpracticecanada.com/spcanada/pdfs/all-allergens/RC294.pdf
Sources: http://www.ncbi.nlm.nih.gov/pubmed/18845111
Curator's Comment: Description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/3180764 and https://www.smartpracticecanada.com/spcanada/pdfs/all-allergens/RC294.pdf
Morpholinylmercaptobenzothiazole is a chemical allergen, it is used in the vulcanization of rubber. It is used for diagnosis of contact allergy. It is a component of Mercapto Mix, used in the epicutaneous patch test, called T.R.U.E. TEST, approved by FDA in 1994. T.R.U.E. TEST is indicated for use as an aid in the diagnosis of allergic contact dermatitis in persons 18 years of age and older whose history suggests sensitivity to one or more of the 35 substances included on the T.R.U.E. TEST panels.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Diagnostic | T.R.U.E. TEST Approved UseT.R.U.E. TEST is an epicutaneous patch test indicated for use as an aid in the diagnosis of allergic contact dermatitis in persons 18 years of age and older whose history suggests sensitivity to one or more of the 35 substances included on the T.R.U.E. TEST panels. Launch Date1993 |
Doses
| Dose | Population | Adverse events |
|---|---|---|
0.5 % single, topical Recommended |
healthy, ADULT Health Status: healthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
Other AEs: Contact dermatitis... |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Contact dermatitis | 1% | 0.5 % single, topical Recommended |
healthy, ADULT Health Status: healthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Patch test results with the metalworking fluid series of the German Contact Dermatitis Research Group (DKG). | 2004-09 |
|
| Stability of the mercaptobenzothiazole compounds. | 1993-01 |
|
| Comparative studies of the sensitization potential of morpholine, 2-mercaptobenzothiazole and 2 of their derivatives in guinea pigs. | 1988-07 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:02:46 GMT 2025
by
admin
on
Mon Mar 31 18:02:46 GMT 2025
|
| Record UNII |
VCD7623F3K
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000185508
Created by
admin on Mon Mar 31 18:02:46 GMT 2025 , Edited by admin on Mon Mar 31 18:02:46 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
70078
Created by
admin on Mon Mar 31 18:02:46 GMT 2025 , Edited by admin on Mon Mar 31 18:02:46 GMT 2025
|
PRIMARY | |||
|
100000134273
Created by
admin on Mon Mar 31 18:02:46 GMT 2025 , Edited by admin on Mon Mar 31 18:02:46 GMT 2025
|
PRIMARY | |||
|
N0000171131
Created by
admin on Mon Mar 31 18:02:46 GMT 2025 , Edited by admin on Mon Mar 31 18:02:46 GMT 2025
|
PRIMARY | Allergens [Chemical/Ingredient] | ||
|
N0000184306
Created by
admin on Mon Mar 31 18:02:46 GMT 2025 , Edited by admin on Mon Mar 31 18:02:46 GMT 2025
|
PRIMARY | Cell-mediated Immunity [PE] | ||
|
102-77-2
Created by
admin on Mon Mar 31 18:02:46 GMT 2025 , Edited by admin on Mon Mar 31 18:02:46 GMT 2025
|
PRIMARY | |||
|
DTXSID0021096
Created by
admin on Mon Mar 31 18:02:46 GMT 2025 , Edited by admin on Mon Mar 31 18:02:46 GMT 2025
|
PRIMARY | |||
|
203-052-4
Created by
admin on Mon Mar 31 18:02:46 GMT 2025 , Edited by admin on Mon Mar 31 18:02:46 GMT 2025
|
PRIMARY | |||
|
2867
Created by
admin on Mon Mar 31 18:02:46 GMT 2025 , Edited by admin on Mon Mar 31 18:02:46 GMT 2025
|
PRIMARY | |||
|
VCD7623F3K
Created by
admin on Mon Mar 31 18:02:46 GMT 2025 , Edited by admin on Mon Mar 31 18:02:46 GMT 2025
|
PRIMARY | |||
|
7619
Created by
admin on Mon Mar 31 18:02:46 GMT 2025 , Edited by admin on Mon Mar 31 18:02:46 GMT 2025
|
PRIMARY | |||
|
40860-79-5
Created by
admin on Mon Mar 31 18:02:46 GMT 2025 , Edited by admin on Mon Mar 31 18:02:46 GMT 2025
|
SUPERSEDED | |||
|
SUB61032
Created by
admin on Mon Mar 31 18:02:46 GMT 2025 , Edited by admin on Mon Mar 31 18:02:46 GMT 2025
|
PRIMARY | |||
|
VCD7623F3K
Created by
admin on Mon Mar 31 18:02:46 GMT 2025 , Edited by admin on Mon Mar 31 18:02:46 GMT 2025
|
PRIMARY | |||
|
DB14202
Created by
admin on Mon Mar 31 18:02:46 GMT 2025 , Edited by admin on Mon Mar 31 18:02:46 GMT 2025
|
PRIMARY | |||
|
N0000175629
Created by
admin on Mon Mar 31 18:02:46 GMT 2025 , Edited by admin on Mon Mar 31 18:02:46 GMT 2025
|
PRIMARY | Increased Histamine Release [PE] |